Vancomycin-based tracers guiding in situ visualization of bacteria on osteosynthesis devices and surgical debridement

Eur J Nucl Med Mol Imaging. 2025 Aug;52(10):3877-3890. doi: 10.1007/s00259-025-07249-4. Epub 2025 Apr 2.

Abstract

Purpose: Bacterial infections associated with musculoskeletal injuries are challenging to detect and distinguish from sterile inflammation. Here we present the combined first-time application of a bacteria-targeted positron emission tomography (PET) tracer and a near-infrared fluorescent tracer to detect infected osteosynthesis implants and guide surgical treatment.

Methods: To this end, osteosynthesis plates covered with bacterial biofilm and pre-incubated with [18F]PQ-VE1-vancomycin for PET imaging and/or vancomycin-IRDye800CW for optical imaging were fixed to post-mortem human tibiae and femora. PET/CT and fluorescence imaging were used to quantify the bacterial load before and after surgical debridement.

Results: Pre-debridement, PET imaging showed a significant 2.2-fold higher tracer uptake on biofilm-covered plates compared to plates without biofilm (p < 0.001). Post-debridement, the PET signal was marginal, demonstrating effective biofilm removal. Fluorescence-guided surgery enabled real-time visualization and removal of bacterial biofilms.

Conclusion: Combined preoperative PET and intraoperative fluorescence imaging with vancomycin-based tracers allows noninvasive detection and real-time infection management, as demonstrated by these preliminary findings.

Keywords: Bacterial biofilm; Bacterial imaging agents; Debridement; Fluorescence guided surgery; Fracture-related infections; Human post-mortem; Near infrared fluorescence; Positron emission tomography; Vancomycin.

MeSH terms

  • Biofilms
  • Debridement*
  • Humans
  • Male
  • Positron Emission Tomography Computed Tomography
  • Radioactive Tracers
  • Vancomycin*

Substances

  • Vancomycin
  • Radioactive Tracers